Luming Liu
- Cancer Research top 5%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 11
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 5
- Cancer survivorship and care 3
- Toxicology top 5%
- Otorhinolaryngology top 10%
-
- Cancer Mechanisms and Therapy 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Renal cell carcinoma treatment 2
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Zhiqiang MengZhen ChenPeng WangLorenzo CohenJie FanLianyu ChenBob ThorntonLiping Zhuang
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Luming Liu
30 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 314
- Oncology 549
- Complementary and alternative medicine 143
- Toxicology 35
- Otorhinolaryngology 38
Countries citing papers authored by Luming Liu
This map shows the geographic impact of Luming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luming Liu more than expected).
Fields of papers citing papers by Luming Liu
This network shows the impact of papers produced by Luming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luming Liu. The network helps show where Luming Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luming Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 27 | |
| 2 | 2020 | 24 | |
| 3 | 2019 | 47 | |
| 4 | 2019 | 17 | |
| 5 | 2017 | 17 | |
| 6 | Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts. | 2017 | 44 |
| 7 | 2016 | 14 | |
| 8 | 2016 | 5 | |
| 9 | 2015 | 12 | |
| 10 | 2014 | 137 | |
| 11 | 2013 | 30 | |
| 12 | 2013 | 126 | |
| 13 | 2012 | 166 | |
| 14 | 2011 | 78 | |
| 15 | 2011 | 77 | |
| 16 | 2010 | 43 | |
| 17 | 2010 | 13 | |
| 18 | 2009 | 246 | |
| 19 | A comparison between gemcitabine-based combination chemotherapy and gemcitabine alone on advanced pancreatic cancer:a Meta-analysis in phase III clinical trials | 2008 | 1 |
| 20 | Effect of Qingyi Huaji Formula on Serum Immunosuppressive Factors and Immune Function of Splenic Lymphocytes in Mice with Pancreatic Cancer | 2008 | 2 |
About Luming Liu
Luming Liu is a scholar working on Oncology, Hepatology and Pharmacology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Cells and Metastasis (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Mechanisms and Therapy (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer survivorship and care (3 papers), Renal cell carcinoma treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (314 citations), Oncology (549 citations) and Complementary and alternative medicine (143 citations). Luming Liu has collaborated with scholars based in China, United States and India. Frequent co-authors include Zhiqiang Meng, Zhen Chen, Peng Wang, Lorenzo Cohen, Jie Fan, Lianyu Chen, Bob Thornton, Liping Zhuang, David Chang and Yehua Shen. Their work appears in journals such as Cancer, Integrative Cancer Therapies, Pancreas, Supportive Care in Cancer and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.